DNA sequence of Ashkenazi Jews mapped
9/11/2014
First DNA sequence dataset of complete Ashkenazi genomes supports targeted personalized medicine, aids disease research across populations, and reveals Jewish and European origins.
New application of surgical aid used by bone cancer surgical team
9/11/2014
An ortho-oncology team at Dartmouth-Hitchcock Norris Cotton Cancer Center successfully adapted a shoulder surgical aid (the Spider Limb Positioner) to conduct a left hip disarticulation on a melanoma...
Leukemia patients to benefit from novel cancer drug
9/11/2014
Results of a Phase I clinical trial showed that a new drug targeting mitochondrial function in human cancer cells was safe and showed some efficacy.
Memory loss more common in people with blood type AB
9/10/2014
Researchers have found that although people with blood type AB only make up 4% of the US population, those with this blood type are 82% more likely to develop memory problems.
The American Association for Cancer Research (AACR) issued a policy statement Tuesday, Sept.
Using immunotoxins to kill colon cancer
9/10/2014
These days, cancer researchers aim to design targeted and specific therapy - those that kill cancer but spare the surrounding tissue.
There is an active controversy among oncologists about when to treat prostate cancer patients, with some suggesting that the word "cancer" be removed from the description of low grade disease, in...
Many skin cancers driven by ultraviolet light-induced mutation
9/10/2014
A genetic mutation caused by ultraviolet light is likely the driving force behind millions of human skin cancers, according to researchers at the Stanford University School of Medicine.
Popular cancer drug target implicated in cardiovascular defects
9/10/2014
Research led by UNC's Kathleen Caron, Ph.D., shows that halting the protein CXCR7 leads to over activation of adrenomedullin, a hormone needed at proper levels for normal cardiovascular development.
Combined therapy improves survival for patients with liver cancer who are not suitable for surgery
9/10/2014
The mature results from a trial conducted by the Asia-Pacific Hepatocellular Carcinoma Trials Group led by the National Cancer Centre Singapore (NCCS) and Singapore General Hospital (SGH) have shown...